Internal Medicine, Hematology & Oncology · Athens, GA
NPI
1285831677
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
125 King Ave Ste 200
Athens, GA, 30606
Phone (770) 496-9400
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.4M
310,876 services
Medicare patients, 2024
1,144
Average age 75
Drug cost, 2024
$4.4M
3,046 prescriptions
Company payments, 2025
$3,182
From 45 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeremy C Wells was code J1439 (injection, ferric carboxymaltose, 1 mg), 51,750 times for 35 patients. In total Jeremy C Wells billed 310,876 services in 197 codes, and Medicare paid $4.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 51,750 | 35 | $0.87 | $45K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 18,803 | 156 | $0.10 | $1,907 |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 17,340 | 19 | $0.27 | $4,632 |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 15,525 | 28 | $2.32 | $36K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 15,000 | 13 | $44.53 | $668K |
| J0897 Injection, denosumab, 1 mg | Office | 14,640 | 112 | $20.66 | $302K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 14,140 | 11 | $0.06 | $800 |
| J0185 Injection, aprepitant, 1 mg | Office | 11,700 | 30 | $1.33 | $16K |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 4,488 | 14 | $21.51 | $97K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,696 | 70 | $0.09 | $241 |
| 36415 Venipuncture Blood Collection | Office | 2,650 | 879 | $8.61 | $23K |
| 85025 Blood Count | Office | 2,605 | 869 | $7.57 | $20K |
| 80053 Clinical Chemistry | Office | 2,347 | 826 | $10.32 | $24K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,850 | 41 | $0.75 | $1,391 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 1,290 | 30 | $0.25 | $322 |
By year: 2022 $4.8M for 362,788 services; 2023 $4.1M for 291,709 services; 2024 $4.4M for 310,876 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 2,650 | 879 | $8.61 | $23K |
| 85025 Blood Count | 2,605 | 869 | $7.57 | $20K |
| 80053 Clinical Chemistry | 2,347 | 826 | $10.32 | $24K |
| 83540 Clinical Chemistry | 420 | 250 | $6.34 | $2,663 |
| 82728 Clinical Chemistry | 420 | 250 | $13.36 | $5,611 |
| 84466 Clinical Chemistry | 402 | 244 | $12.50 | $5,025 |
| 82378 Clinical Chemistry | 248 | 98 | $18.45 | $4,576 |
| 83615 Clinical Chemistry | 244 | 135 | $5.92 | $1,444 |
| 86300 Immunoassay | 201 | 87 | $20.19 | $4,058 |
| 84153 Clinical Chemistry | 193 | 73 | $18.02 | $3,478 |
Medicare prescription drug claims, 2024
In 2024, the drug Jeremy C Wells prescribed most often to Medicare patients was Letrozole, with 235 prescriptions and refills. In total Jeremy C Wells wrote 3,046 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 235 | 488 | 70 | $4,759 |
| Anastrozole Generic | 188 | 456 | 48 | $3,162 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 167 | 167 | 46 | $6,869 |
| Prednisone Generic | 131 | 145 | 45 | $805 |
| Gabapentin Generic | 130 | 140 | 27 | $1,171 |
| Oxycodone Hcl Generic | 90 | 90 | 28 | $1,415 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 90 | 116 | 22 | $889 |
| Ondansetron Hcl Generic | 75 | 79 | 48 | $2,441 |
| Abiraterone Acetate Generic | 67 | 67 | Under 11 | $120K |
| Dexamethasone Generic | 64 | 73 | 30 | $847 |
| Pantoprazole Sodium Generic | 61 | 99 | 22 | $504 |
| Potassium Chloride Generic | 59 | 65 | 30 | $424 |
| Eliquis Apixaban | 59 | 77 | Under 11 | $43K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 58 | 59 | 29 | $956 |
| Acyclovir Generic | 53 | 73 | Under 11 | $833 |
Brand drugs: 386 claims; generic drugs: 2,660 claims; opioid claims: 440.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeremy C Wells $3,182 ($3,182 in general payments such as food, travel and fees) from 45 companies. The largest payer was Daiichi Sankyo Inc. with $405.
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. 4568.T | 14 | $405 |
| Novartis Pharmaceuticals Corporation NVS | 12 | $323 |
| E.R. Squibb & Sons, L.L.C. BMY | 12 | $209 |
| Pfizer Inc. PFE | 8 | $175 |
| BeOne Medicines USA, Inc. ONC | 7 | $146 |
| Abbvie Inc. ABBV | 10 | $135 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $132 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $122 |
| Gilead Sciences, Inc. GILD | 5 | $112 |
| EMD Serono, Inc. MRK.DE | 4 | $90.75 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.